ENDRA Life Sciences Inc. (NDRA)Healthcare | Diagnostics & Research | Ann Arbor, United States | NasdaqCM
6.40 USD
+1.23
(23.791%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 6.07 -0.33 (-0.330%) ⇩ (April 17, 2026, 7:16 p.m. EDT) Short-term: ★★☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 11, 2026, 3:46 p.m. EDT
NDRA (ENDRA Life Sciences Inc.) shows mixed signals. The recent price history indicates some upward momentum, with a recent close of $4.94, which is above the 50-day average of $3.8979. However, the stock has been volatile, with significant swings in the past 14 days. The forward PE is negative, indicating potential earnings issues, and the company's fundamentals are weak, as seen in the negative return on assets and equity. The stock has a low market cap, suggesting it's highly speculative. The recent news highlights strategic alternatives and potential earnings, which could be positive, but the overall financial health of the company is concerning. There are no dividends, so dividend investors should avoid this stock. Given the uncertainty and weak fundamentals, it's not advisable to invest for the long term. For short-term traders, the stock's recent performance and potential for a short-term rally could be a buying opportunity, but the high risk should be carefully considered. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.192057 |
| AutoTheta | 0.194183 |
| AutoARIMA | 0.196470 |
| AutoETS | 0.201782 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 77% |
| H-stat | 1.09 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.142 |
| Excess Kurtosis | -0.70 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 21.784 |
| Market Cap | 7,940,806 |
| Forward P/E | -1.60 |
| Beta | -0.22 |
| Website | https://endrainc.com |
| Attribute | Value |
|---|---|
| 52 Week Change | 0.9047619 |
| Address1 | 3,600 Green Court |
| Address2 | Suite 350 |
| All Time High | 205,800.0 |
| All Time Low | 2.9 |
| Ask | 7.93 |
| Ask Size | 2 |
| Average Analyst Rating | 1.0 - Strong Buy |
| Average Daily Volume10 Day | 24,020 |
| Average Daily Volume3 Month | 112,567 |
| Average Volume | 112,567 |
| Average Volume10Days | 24,020 |
| Beta | -0.223 |
| Bid | 4.63 |
| Bid Size | 2 |
| Book Value | 1.921 |
| City | Ann Arbor |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 6.4 |
| Current Ratio | 1.289 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 6.69 |
| Day Low | 5.14 |
| Debt To Equity | 21.784 |
| Display Name | ENDRA Life Sciences |
| Earnings Call Timestamp End | 1,724,358,600 |
| Earnings Call Timestamp Start | 1,724,358,600 |
| Earnings Timestamp End | 1,756,123,200 |
| Earnings Timestamp Start | 1,755,687,540 |
| Ebitda | -5,719,056 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -1.341 |
| Enterprise Value | 7,670,793 |
| Eps Current Year | -4.65 |
| Eps Forward | -4.0 |
| Eps Trailing Twelve Months | -8.93 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 4.0561 |
| Fifty Day Average Change | 2.3439002 |
| Fifty Day Average Change Percent | 0.5778704 |
| Fifty Two Week Change Percent | 90.47619 |
| Fifty Two Week High | 11.96 |
| Fifty Two Week High Change | -5.56 |
| Fifty Two Week High Change Percent | -0.46488294 |
| Fifty Two Week Low | 2.9 |
| Fifty Two Week Low Change | 3.5 |
| Fifty Two Week Low Change Percent | 1.2068965 |
| Fifty Two Week Range | 2.9 - 11.96 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,498,829,400,000 |
| Float Shares | 1,169,842 |
| Forward Eps | -4.0 |
| Forward P E | -1.6 |
| Free Cashflow | -6,020,649 |
| Full Exchange Name | NasdaqCM |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.3734 |
| Held Percent Institutions | 0.15762 |
| Implied Shares Outstanding | 1,240,751 |
| Industry | Diagnostics & Research |
| Industry Disp | Diagnostics & Research |
| Industry Key | diagnostics-research |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,730,937,600 |
| Last Split Factor | 1:35 |
| Long Business Summary | ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source comprising radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan. |
| Long Name | ENDRA Life Sciences Inc. |
| Market | us_market |
| Market Cap | 7,940,806 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_52323443 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -7,027,410 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 7,940,806 |
| Number Of Analyst Opinions | 1 |
| Open | 5.1432 |
| Operating Cashflow | -5,182,558 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 734 335 0468 |
| Post Market Change | -0.32999992 |
| Post Market Change Percent | -5.1562486 |
| Post Market Price | 6.07 |
| Post Market Time | 1,776,467,776 |
| Previous Close | 5.17 |
| Price Eps Current Year | -1.3763441 |
| Price Hint | 2 |
| Price To Book | 3.3315983 |
| Profit Margins | 0.0 |
| Quick Ratio | 1.015 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.0 |
| Region | US |
| Regular Market Change | 1.23 |
| Regular Market Change Percent | 23.7911 |
| Regular Market Day High | 6.69 |
| Regular Market Day Low | 5.14 |
| Regular Market Day Range | 5.14 - 6.69 |
| Regular Market Open | 5.1432 |
| Regular Market Previous Close | 5.17 |
| Regular Market Price | 6.4 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 81,476 |
| Return On Assets | -0.86728996 |
| Return On Equity | -2.9156399 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 1,240,751 |
| Shares Percent Shares Out | 0.0425 |
| Shares Short | 52,702 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 154,773 |
| Short Name | ENDRA Life Sciences Inc. |
| Short Percent Of Float | 0.045 |
| Short Ratio | 0.78 |
| Source Interval | 15 |
| State | MI |
| Symbol | NDRA |
| Target High Price | 27.0 |
| Target Low Price | 27.0 |
| Target Mean Price | 27.0 |
| Target Median Price | 27.0 |
| Total Cash | 762,365 |
| Total Cash Per Share | 0.614 |
| Total Debt | 492,352 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -8.93 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 4.996455 |
| Two Hundred Day Average Change | 1.4035449 |
| Two Hundred Day Average Change Percent | 0.28090814 |
| Type Disp | Equity |
| Volume | 81,476 |
| Website | https://endrainc.com |
| Zip | 48,105-1570 |